2019
DOI: 10.1038/s41598-019-38565-z
|View full text |Cite
|
Sign up to set email alerts
|

Experimental Tracheal Replacement Using 3-dimensional Bioprinted Artificial Trachea with Autologous Epithelial Cells and Chondrocytes

Abstract: Various treatment methods for tracheal defects have been attempted, such as artificial implants, allografts, autogenous grafts, and tissue engineering; however, no perfect method has been established. We attempted to create an effective artificial trachea via a tissue engineering method using 3D bio-printing. A multi-layered scaffold was fabricated using a 3D printer. Polycaprolactone (PCL) and hydrogel were used with nasal epithelial and auricular cartilage cells in the printing process. An artificial trachea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
52
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 73 publications
(53 citation statements)
references
References 38 publications
0
52
0
1
Order By: Relevance
“…Tissue engineering approaches can address the unmet demand for the replacement, repair, and regeneration of organs and tissues [4][5][6][7] . There has been remarkable success in the clinical translation of 3D tissueengineered constructs for repairing organs, such as the trachea 8,9 and lungs; 10 however, multiple challenges remain unaddressed. These challenges include (i) the preservation of high cell viability postimplantation, (ii) the unwanted immune response, (iii) the obstruction of cell signaling pathways, (iv) insufficient cell proliferation, and (v) low metabolic activity within the implanted scaffolds.…”
Section: Tissue Engineering: Current Need and Limitationsmentioning
confidence: 99%
“…Tissue engineering approaches can address the unmet demand for the replacement, repair, and regeneration of organs and tissues [4][5][6][7] . There has been remarkable success in the clinical translation of 3D tissueengineered constructs for repairing organs, such as the trachea 8,9 and lungs; 10 however, multiple challenges remain unaddressed. These challenges include (i) the preservation of high cell viability postimplantation, (ii) the unwanted immune response, (iii) the obstruction of cell signaling pathways, (iv) insufficient cell proliferation, and (v) low metabolic activity within the implanted scaffolds.…”
Section: Tissue Engineering: Current Need and Limitationsmentioning
confidence: 99%
“…Regenerative medicine promises autologous and tailor-made tissue substitutes without the need of immunosuppression 5 . For this reason, more and more tissue engineered tracheal replacements have arisen in recent past 6,7 . Nevertheless, these strategies still face challenges regarding vascularization, mechanical stiffness and proper epithelization 8,9 .…”
mentioning
confidence: 99%
“…Also, a bio-printed conduit manufactured with endothelial cell-containing, 3% alginate and a porous PCL structure was found to exhibit the expression of cells after application of a simulation system reflective of hemodynamics for 2 weeks [13]. Finally, the results of an artificial tracheal study showed that 3% alginate mixed with autologous epithelial and chondrocytes could be printed with PCL and support cell viability, showing dead cells at levels less than 20% from the third day [11]. Accordingly, we hypothesized that the fabrication of artificial vessels that are small in diameter with biodegradable PCL, an appropriate content of alginate, and a sufficient amount of autologous cells would protect against graft failure stemming from thrombosis, neo-intimal hyperplasia, and immune rejection.…”
Section: Introductionmentioning
confidence: 92%
“…In studies using 3D bio-printing with alginate solutions, 3% alginate was deemed an appropriate concentration with which to protect against physical denaturation [10], compared to 2.5% alginate, which, despite chemical crosslinking with CaCl2, facilitated poor formation of the designed pattern [10,11]. In addition to use in the cardiovascular system, constructing a double-structured conduit combining bio-printed alginate hydrogels and a biodegradable polycaprolactone (PCL) scaffold has been found to be beneficial in applications for treating the cranial nervous system and airway track: In the conduit in which alginate containing neurons and a porous PCL scaffold were combined, a uniform cell distribution and the same proliferation rate as that in plate media were confirmed [12].…”
Section: Introductionmentioning
confidence: 99%